S'abonner

Intrinsically defective skin barrier function in children with atopic dermatitis correlates with disease severity - 15/08/11

Doi : 10.1016/j.jaci.2007.12.1161 
Jayanta Gupta, MD a, d, Emilie Grube, BA b, Mark B. Ericksen, BS b, d, Michelle D. Stevenson, MD, MS e, Anne W. Lucky, MD c, Anita P. Sheth, MD c, Amal H. Assa’ad, MD b, Gurjit K. Khurana Hershey, MD, PhD b, d,
a Division of Epidemiology and Biostatistics, Department of Environmental Health, University of Cincinnati College of Medicine, Cincinnati, Ohio 
b Division of Allergy and Immunology, Cincinnati Children’s Hospital Medical Center, University of Cincinnati College of Medicine, Cincinnati, Ohio 
c Division of Pediatric Dermatology, Cincinnati Children’s Hospital Medical Center, University of Cincinnati College of Medicine, Cincinnati, Ohio 
d Institute of Personalized and Predictive Medicine, Cincinnati Children’s Hospital Medical Center, University of Cincinnati College of Medicine, Cincinnati, Ohio 
e Division of Emergency Medicine, Cincinnati Children’s Hospital Medical Center, and the Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, Ohio 

Reprint requests: Gurjit K. Khurana Hershey, MD, PhD, Institute of Personalized and Predictive Medicine and Division of Allergy and Immunology, Department of Pediatrics, Cincinnati Children’s Hospital Medical Center, 3333 Burnet Ave, MLC 7028, Cincinnati, OH 45229.

Abstract

Background

Recent genetic evidence supports that an underlying defect in skin barrier function contributes to the pathogenesis of atopic dermatitis (AD). The integrity of the skin barrier can be assessed objectively by measuring transepidermal water loss (TEWL). Previous investigations of TEWL as a biomarker of skin barrier function have been limited by small sample size, and studies including African American subjects are lacking.

Objective

We sought to determine whether children with AD have inherently altered skin barrier function by comparing TEWL as a measure of skin barrier function in African American and white children with AD with that in control subjects without AD.

Methods

TEWL was measured on nonlesional normal-appearing skin at 4 sites (the volar forearm, dorsal arm, lower leg, and cheek) in (1) children with AD (cases), (2) children with asthma or allergic rhinitis but without AD (allergic control subjects), and (3) nonatopic control subjects. AD severity was assessed by using the objective SCORAD index.

Results

TEWL was increased in children with AD compared with that seen in both control groups at most of the anatomic sites tested (P < .05). TEWL also correlated with objective SCORAD score. The presence of allergic sensitization or other allergic conditions did not affect TEWL among children with AD. TEWL was higher in white than in African American children.

Conclusion

Skin barrier function as assessed by TEWL is intrinsically compromised in children with AD but not in children with other allergic conditions. The magnitude of skin barrier dysfunction correlates with AD disease severity.

Le texte complet de cet article est disponible en PDF.

Key words : Atopic dermatitis, transepidermal water loss, objective SCORAD, African American, white

Abbreviations used : AD, TEWL


Plan


 Supported by National Institutes of Health grant U19A170235-01 (GKKH) and the University of Cincinnati, Molecular Epidemiology in Children’s Environmental Health–Institutional NIEHS T32 ES10957 (MDS) and Cincinnati Children’s Hospital Medical Center–Institutional NICHD T32 HD43005 (MDS).
 Disclosure of potential conflict of interest: The authors have declared that they have no conflict of interest.


© 2008  American Academy of Allergy, Asthma & Immunology. Publié par Elsevier Masson SAS. Tous droits réservés.
Ajouter à ma bibliothèque Retirer de ma bibliothèque Imprimer
Export

    Export citations

  • Fichier

  • Contenu

Vol 121 - N° 3

P. 725 - mars 2008 Retour au numéro
Article précédent Article précédent
  • Contribution of allergen-specific and nonspecific nasal responses to early-phase and late-phase nasal responses
  • Satoko Miyahara, Nobuaki Miyahara, Joseph J. Lucas, Anthony Joetham, Shikegi Matsubara, Hiroshi Ohnishi, Azzeddine Dakhama, Erwin W. Gelfand
| Article suivant Article suivant
  • Early clinical predictors of remission of peanut allergy in children
  • Marco H.K. Ho, Wilfred H.S. Wong, Ralf G. Heine, Clifford S. Hosking, David J. Hill, Katrina J. Allen

Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.

Déjà abonné à cette revue ?

Mon compte


Plateformes Elsevier Masson

Déclaration CNIL

EM-CONSULTE.COM est déclaré à la CNIL, déclaration n° 1286925.

En application de la loi nº78-17 du 6 janvier 1978 relative à l'informatique, aux fichiers et aux libertés, vous disposez des droits d'opposition (art.26 de la loi), d'accès (art.34 à 38 de la loi), et de rectification (art.36 de la loi) des données vous concernant. Ainsi, vous pouvez exiger que soient rectifiées, complétées, clarifiées, mises à jour ou effacées les informations vous concernant qui sont inexactes, incomplètes, équivoques, périmées ou dont la collecte ou l'utilisation ou la conservation est interdite.
Les informations personnelles concernant les visiteurs de notre site, y compris leur identité, sont confidentielles.
Le responsable du site s'engage sur l'honneur à respecter les conditions légales de confidentialité applicables en France et à ne pas divulguer ces informations à des tiers.


Tout le contenu de ce site: Copyright © 2024 Elsevier, ses concédants de licence et ses contributeurs. Tout les droits sont réservés, y compris ceux relatifs à l'exploration de textes et de données, a la formation en IA et aux technologies similaires. Pour tout contenu en libre accès, les conditions de licence Creative Commons s'appliquent.